Change in the taste with the cancer chemotherapy and effort to zinc supplement
Not Applicable
- Conditions
- Clinical oncology
- Registration Number
- JPRN-UMIN000034332
- Lead Sponsor
- wajima City Hospital Department of Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with the taste obstacle Patient with cognitive disfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie taste changes in cancer patients undergoing chemotherapy?
How does zinc supplementation compare to standard-of-care treatments in managing chemotherapy-induced taste alterations?
Are there specific biomarkers that predict the efficacy of zinc supplementation in patients with chemotherapy-related taste disturbances?
What are the potential adverse events associated with zinc supplementation during cancer chemotherapy and how can they be managed?
What other compounds or combination therapies have shown promise in addressing taste changes in cancer patients alongside zinc supplementation?